Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests

Mallick, 2007, Computational prediction of proteotypic peptides for quantitative proteomics, Nat. Biotechnol., 25, 125, 10.1038/nbt1275 Gerber, 2003, Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS, Proc. Natl. Acad. Sci. U. S. A., 100, 6940, 10.1073/pnas.0832254100 Anderson, 2006, Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins, Mol. Cell. Proteomics, 5, 573, 10.1074/mcp.M500331-MCP200 Keshishian, 2007, Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution, Mol. Cell. Proteomics, 6, 2212, 10.1074/mcp.M700354-MCP200 Kulasingam, 2008, “Product ion monitoring” assay for prostate-specific antigen in serum using a linear ion-trap, J. Proteome Res., 7, 640, 10.1021/pr7005999 Lin, 2006, Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap, Anal. Chem., 78, 5762, 10.1021/ac060613f Wu, 2002, Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system, J. Proteome Res., 1, 459, 10.1021/pr025537l Oe, 2006, Quantitative analysis of amyloid β peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry, Rapid Commun. Mass Spectrom., 20, 3723, 10.1002/rcm.2787 Whiteaker, 2007, Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer, Anal. Biochem., 362, 44, 10.1016/j.ab.2006.12.023 Rafferty, 2000, Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10), Clin. Chem., 46, 1310, 10.1093/clinchem/46.9.1310 Barnidge, 2004, Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry, J. Proteome Res., 3, 644, 10.1021/pr049963d Steel, 2003, Efficient and specific removal of albumin from human serum samples, Mol. Cell. Proteomics, 2, 262, 10.1074/mcp.M300026-MCP200 Granger, 2005, Albumin depletion of human plasma also removes low abundance proteins including the cytokines, Proteomics, 5, 4713, 10.1002/pmic.200401331 Semjonow, 1996, Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values, Prostate Suppl., 7, 3, 10.1002/(SICI)1097-0045(1996)7+<3::AID-PROS1>3.0.CO;2-T McCormack, 1995, Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era, Urology, 45, 729, 10.1016/S0090-4295(99)80076-4 Prestigiacomo, 1995, Clinical usefulness of free and complexed PSA, Scand. J. Clin. Lab. Investig, 221, 32, 10.3109/00365519509090561 Zhang, 1998, Characterization and immunological determination of the complex between prostate-specific antigen and α2-macroglobulin, Clin Chem., 44, 2471, 10.1093/clinchem/44.12.2471 Zisman, 1995, Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia, J. Urol., 154, 1052, 10.1016/S0022-5347(01)66974-X McNeel, 2000, Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer, J. Urol., 164, 1825, 10.1016/S0022-5347(05)67114-5 Tomer, 2000, 141 Pratt, 2006, Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes, Nat. Protoc., 1, 1029, 10.1038/nprot.2006.129 Brun, 2007, Isotope-labeled protein standards: toward absolute quantitative proteomics, Mol. Cell. Proteomics, 6, 2139, 10.1074/mcp.M700163-MCP200 Kuhn, 2004, Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards., Proteomics, 4, 1175, 10.1002/pmic.200300670